Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
01/2004
01/01/2004US20040003424 Transgenic cardiomyocytes with controlled proliferation and differentiation
01/01/2004US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass
01/01/2004US20040003421 Lysosomal proteins produced in the milk of transgenic animals
01/01/2004US20040003420 A fusion protein containing a recombinase domain consists of a recombinase protein or a mutant having a recombinase activity similar to wild type recombinase, and a signal peptide domain linked to such recombinase domain
01/01/2004US20040003419 Novel taste receptors in Drosophila
01/01/2004US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
01/01/2004US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor
01/01/2004US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom
01/01/2004US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid
01/01/2004US20040001810 Administering dosage of nucleic acids; cardiovascular disorders
12/2003
12/31/2003WO2004001409A2 Method for screening modulators of the transmission of immunity
12/31/2003WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
12/31/2003WO2004000011A2 Methods for developing animal models
12/31/2003WO2004000010A2 Animal models of prostate cancer and methods for their use
12/31/2003WO2003081990A3 Improved method for generating genetically modified animals
12/31/2003WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003064465A3 Prkag3 gene promoter and uses thereof
12/31/2003WO2003057719A3 Methods of modulating localization and physiological function of ip3 receptors
12/31/2003WO2003056022A3 Method for producing a transgenic organism using a lentiviral expression vector such as eiav
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003054151A3 Generation of transgenic mice by transgene-mediated rescue of spermatogenesis
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002036789A3 Methods of modifying eukaryotic cells
12/31/2003CN1463596A Freshwater prawn transvaalensis method
12/31/2003CN1463595A Method for cultivating scallop hybrids
12/31/2003CN1463594A Method for building virus hepatitis mice model
12/31/2003CN1463593A Process for preparing type C hepatitis virus natural infestation mice model and use thereof
12/31/2003CN1463592A Method for raising and breeding wild boar and special type wild boar
12/31/2003CN1463591A An ecological method for producing farm and side line products
12/31/2003CN1132514C Method for selectively breeding white fragrant pig
12/31/2003CA2490753A1 Methods for developing animal models
12/31/2003CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease
12/30/2003US6670451 Netrins
12/30/2003US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003CA2224663C Animal feed compositions and uses of triterpenoid saponin obtained from camellia l. plants
12/25/2003US20030237106 Transgenic animal containing CD200 and uses therefor
12/25/2003US20030237104 Methods for developing animal models
12/25/2003US20030237103 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/25/2003US20030237102 Method of reducing neuronal electrical activity with a potassium channel subunit
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235886 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
12/25/2003US20030235845 Directing splicing of messenger RNA associated with dystrophin protein for diagnosis and treatment of muscular dystrophy
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235826 Gene and protein specific for excitable tissues
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030233982 Raising fly larvae as the space food for crew
12/24/2003WO2003106694A2 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors
12/24/2003WO2003105578A1 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide
12/24/2003WO2003105577A1 Drosophila transgenic animal models for myotonic dystrophies
12/24/2003WO2003075647A3 Method and system for in vivo analysis of developmental processes
12/24/2003WO2003072755A3 Transgenic zebrafish models for thrombosis
12/24/2003WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism
12/24/2003WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/24/2003WO2002092764A3 Transgenic animal model of bone mass modulation
12/24/2003WO2002026805A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/23/2003US6667164 Method for determining the MHC genotype of chickens
12/23/2003US6667163 Genetic engineering
12/23/2003US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells.
12/18/2003WO2003104811A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104453A1 Method of constructing antibody
12/18/2003WO2003104431A2 Transgenic mammals expressing polyglutamine
12/18/2003WO2003104261A2 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103378A2 Fish produced by nuclear transfer from cultured cells
12/18/2003WO2003093436A3 Treatment for phenylketonuria
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003066847A3 Phytase variants
12/18/2003WO2003066158A3 Method and apparatus for guiding movement of a freely roaming animal through brain stimulation
12/18/2003WO2003055977A3 A method for generating overexpression of alleles in genes of unknown function
12/18/2003WO2003054167A3 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
12/18/2003WO2003046131A3 Dnmt3l-related cloning and reproductive methods
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
12/18/2003WO2003025146A3 Production of a transgenic avian by cytoplasmic injection
12/18/2003WO2003022040A9 Method for producing transgenic animals
12/18/2003WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
12/18/2003WO2002059298A3 Gab2(p97) gene and methods of use thereof
12/18/2003WO2002058724A3 Use of lp82 to treat body weight disorders
12/18/2003WO2002057440A3 Screens and assays for agents useful in controlling parasitic nematodes
12/18/2003WO2002057423A3 Isolating cells expressing secreted proteins
12/18/2003WO2002020824A3 Process for estimating random error in chemical and biological assays
12/18/2003US20030233669 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
12/18/2003US20030232420 Kinase anchor protein muteins, peptides thereof and related documents
12/18/2003US20030232410 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
12/18/2003US20030232339 Human TRPCC cation channel and uses
12/18/2003US20030232041 For use in food and feeds
12/18/2003CA2488932A1 Transgenic mammals expressing polyglutamine
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370132A2 Use of telomerase reverse transcriptase to create homozygous knockout animals